[ET Net News Agency, 24 November 2025] INNOGEN-B (02591) rose 19.5% to HK$34.6.
It hits an intra-day high of HK$34.78, breaking above the 20-D SMA of HK$31.493, and an
intra-day low of HK$29.1. The total shares traded was 257,040, with a value of HK$8.44m.
The active buy/sell ratio is 77:23, with net buying turnover of HK$4.29m. J.P. MORGAN BRO
(HK) accounts for greatest net responsive buying turnover of HK$624,298, with volume
weighted average price of HK$32.648. FUTU SEC INT'L accounts for greatest net responsive
selling turnover of HK$987,915, with volume weighted average price of HK$33.245.

Basic Information
=================

-----------------------------------
Nominal 34.600 % Chg +19.48%
High 34.780 Low 29.100
Shares Tr 257,040 Turnover 8.44m
10-D SMA 32.530 %H.V 61.138
20-D SMA 31.493 VWAP 32.854
50-D SMA 36.148 RSI14 53.300
-----------------------------------
Status: Breaking above the 20-D SMA, active buy/sell ratio is 77:23, with net buying
turnover of HK$4.29m

Performance of stocks in the same sector or of relevance
========================================================

Stock (Code) Price (HK$) Change (%)
-----------------------------------------------
INNOGEN-B (02591) 34.60 +19.48
INNOVENT BIO (01801) 90.45 +3.67
XTALPI (02228) 10.08 +4.24
WUXI BIO (02269) 31.28 +2.36
WUXI APPTEC (02359) 104.70 +3.15
BEONE MEDICINES (06160) 209.00 +1.46
SKB BIO-B (06990) 444.40 +4.17
DUALITYBIO-B (09606) 316.60 +1.28
AKESO (09926) 110.20 +2.99
REMEGEN (09995) 82.00 +1.36
-----------------------------------------------
(ed)